13th European Headache Congress

Migraine does not take lives but days from your life. Take them back!

Prof. Michelle Xiao Androulakis


Prof. Michelle Xiao Androulakis

Day of Lecture

June 2nd 10:30 - 10:50


Stroke and headache


Board Certified in American Board of Neurology and Psychiatry
Board certified in Headache Medicine

B.        Positions and Honors

  2014-2018                   Clinical Assistant professor, Director of Headache Clinic, SOM, University of South Carolina

2018-now                    Chief of Neurology, Medical Director of Stroke Program, Site Director for Neurology residency program at the Dorn VA Medical Center;

2018-now                    Adjunct assistant professor, Dept. of Neurology, SOM, University of South Carolina



1995          Travel scholarship for training course in Electro-Neurophysiology, University of Toronto        

1996          Travel scholarship for training course in Cell and Tissue Culture              

1994-1996 Canadian Neuroscience Network of Excellence Fellowship

2015          Travel award for International headache academy held at NIH               

2015          Travel award for ANA 7th Annual Translational Clinical Research Course for Clinician-Scientists    

2015, 2016, 2017, 2018          Top Doctors award, Columbia, SC                 

2017, 2018                                          Castle Connolly Exceptional Women award in Medicine                                

2018                Faculty of Scottsdale Headache Symposium

2017-now Fellow of American Headache Society (FAHS)

D.  Research Support       


Project pending IRB approval (site PI):                                                                                                     Oct.,2018- Oct. 2020

Phase 2, multi-center clinical trial using AVP-786-205 on neurobehavioral disinhibition in patients with TBI.


Projects completed (PI):

18450-JA13 (PI, investigator initiated) Sponsored by TX360             August, 2015-2018

Long term outcome and management of headache patients treated with Sphenopalatine Ganglion Block: A registry and functional MRI study

18450-JA17 (Site PI)                                                                                                                                                                         Dec, 2015-2018

Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 (Galcanezumab) in Patients with Episodic Migraine

18450-JA16 (Site PI)                                                                                                                                                                         Dec, 2015-2018

Phase 3, Randomized, Double-Blind, Placebo-Controlled study of LY2951742 (Galcanezumab) in Patients with Chronic Migraine

M-Award 13580-MMA1 (PI, investigator initiated)                                                                      April 2015- June 2016

McCausland Center (M-Fund) for new investigators

A prospective fMRI study on resting state brain activity in healthy subjects and in chronic migraine patients undergoing long term Sphenopalatine ganglion block

18450-E154 (PI, investigator initiated) USC ASPIRE GRANT               Jan 2016-Jan 2017

A prospective fMRI study on brain connectivity in healthy subjects and in chronic migraine patients undergoing long term Sphenopalatine ganglion

ASUBIO (Site PI)                                                                                                                                                                  Mar 2015-Mar 2016

A Phase 2, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SUN13837 Administered Doses (27/28 Days) to Adult Subjects with an Acute Ischemic Stroke

SOCRATEs (Site PI)                                                                                                                                                            May 2014- Dec. 2015

A Randomized, Double blind, multinational study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute ischemic Stroke or TIA


Projects completed (sub-I):


Periodontal treatment to Eliminate Minority in Equality and Rural disparities in Stroke

Brains gate:

Augmenting Cerebral blood flow via Sphenopalatine ganglion stimulation Trial 


Multicenter, randomized, double-blind, double-dummy, active-comparator, event-driven, superiority phase III study of secondary prevention of stroke and prevention of systemic embolism in patients with a recent Embolic Stroke of Undetermined Source (ESUS), comparing rivaroxaban 15 mg once daily with aspirin 100 mg (NAVIGATE ESUS)

PRISMS: Efficacy and Safety of Alteplase in Mild Stroke: Rapidly Improving Symptoms & Minor Neurologic Deficits